drugset / Trial / NCT00627536

Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin Incisions

NCT00627536

Phase 2 Completed 39 enrolled Renovo
RandomizedSingle-groupTriple-blindTreatment

Summary

This study was undertaken to investigate the scar-improvement efficacy and safety of a single dose of avotermin (Juvista) injection into skin incisions.

Timeline

Start
2006-07
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Avotermin Protein / enzyme biologic 5 ng Other
Subject Avotermin Protein / enzyme biologic 50 ng Other
Subject Avotermin Protein / enzyme biologic 200 ng Other
Subject Avotermin Protein / enzyme biologic 500 ng Other

Indications

No indication recorded.